Geron reported $-27976000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US $ 2176M 324M
Cti Biopharma CTIC:US $ -18883000 16.22M
Cytokinetics CYTK:US $ -10874000 66.98M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Exelixis EXEL:US $ 83.71M 463K
Genmab GEN:DC 1.25B 733M
Geron GERN:US $ -27976000 699K
Gilead Sciences GILD:US $ 2029M 868M
Macrogenics MGNX:US $ -41808000 24.83M
Novartis NOVN:VX 3.32B 176M
Pain Therapeutics PTIE:US $ -19917000 2.1M
Seattle Genetics SGEN:US $ -133111000 61K
YTE INCY:US $ 260.29M 132.62M